REQUEST A DEMO
Total
USD $0.00
Search more companies

Endopharm Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Fats and Oils Refining and Blending | All Other Food Manufacturing | All Other Wood Product Manufacturing | Other Basic Organic Chemical Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing
Full name: Endopharm Sp. z o.o. Profile Updated: January 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Endopharm Sp. z o.o. is a company in Poland, with a head office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on January 07, 2020. The latest financial highlights indicate a net sales revenue increase of 77.82% in 2022. A negative growth of 2.86% was recorded in its total assets. The net profit margin of Endopharm Sp. z o.o. increased by 81906.81% in 2022.

Headquarters
Ul. Sienna 83/218
Warsaw; Mazowieckie; Postal Code: 00-815

Contact Details: Purchase the Endopharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Endopharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Endopharm Sp. z o.o. report to view the information.
Incorporation Date:
January 07, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Endopharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
77.82%
Total operating revenue
6566.59%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-29.12%
Total assets
-2.86%
Total equity
-7.54%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
81906.81%
Return on Equity (ROE)
1.17%
Debt to Equity Ratio
4.53%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?